Science Explorer Back to mapMap
Discussion
Company · Redwood City · United States

AcelRx Pharmaceuticals (United States)

acelrx.comROR OpenAlex
Research works
24
▼ 64% vs 2018-21
Citations
236
9.7 per fractional work
Top-10% rate
8.9%
all institutions 10.0%
Open access
36%
world 40%
International
22%
world 18%
AcelRx Pharmaceuticals (United States)

Not ranked overall: AcelRx Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does AcelRx Pharmaceuticals (United States) work in?

In all years, 82% of research at AcelRx Pharmaceuticals (United States) is in Health Sciences, 14% in Life Sciences. Its largest fields are Medicine (82%), Biochemistry, Genetics and Molecular Biology (8%), Engineering (3%). It does 2.6× the world's share of Health Sciences.

Health Sciences: 20 fractional works · 82.0% of its workMedicine: 20 fractional works · 81.7% of its workAnesthesiology and Pain Medicine: 6 fractional works · 24.4% of its workSurgery: 5 fractional works · 19.3% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 9.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 5.6% of its workPhysiology: 1 fractional works · 5.1% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 2.9% of its workEmergency Medicine: 1 fractional works · 2.3% of its workPathology and Forensic Medicine: 1 fractional works · 2.1% of its workPsychiatry and Mental health: 0 fractional works · 2.1% of its workPharmacology: 0 fractional works · 1.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workHematology: 0 fractional works · 1.1% of its workDermatology: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workUrology: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 3 fractional works · 14.3% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 7.9% of its workMolecular Biology: 1 fractional works · 5.1% of its workCancer Research: 1 fractional works · 2.8% of its workImmunology and Microbiology: 1 fractional works · 2.8% of its workImmunology: 0 fractional works · 1.4% of its workMicrobiology: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.8% of its workPharmacology: 1 fractional works · 2.8% of its workNeuroscience: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 3.8% of its workEngineering: 1 fractional works · 3.1% of its workAerospace Engineering: 0 fractional works · 0.7% of its workCivil and Structural Engineering: 0 fractional works · 0.7% of its workMechanics of Materials: 0 fractional works · 0.7% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workMechanical Engineering: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.7% of its workALL ITS WORKAcelRxPharmaceuticals…24fractional works, all years
Life Sciences14%Physical Sciences4%Health Sciences82%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 8 fields, with their numbers
    1. Medicine2081.7%
    2. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology27.9%
    2. Immunology and Microbiology12.8%
    3. Pharmacology, Toxicology and Pharmaceutics12.8%
    4. Neuroscience00.9%
    1. Engineering13.1%
    2. Chemistry00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at AcelRx Pharmaceuticals (United States)?

Ranked on the quality score, Karen P. DiDonato lead among researchers whose main affiliation is AcelRx Pharmaceuticals (United States).

  1. 1 Karen P. DiDonato United States · #1,719,925 worldwide 829 citations · 28 works
All ranked researchers at AcelRx Pharmaceuticals (United States)

What are the most cited papers from AcelRx Pharmaceuticals (United States)?

The most cited paper from AcelRx Pharmaceuticals (United States) is "Research design considerations for chronic pain prevention clinical trials" (Jennifer S. Gewandter et al., 2015), with 145 citations. Next come "Sufentanil Sublingual Tablet System vs. Intravenous Patient‐Controlled Analgesia with Morphine for Postoperative Pain Control: A Randomized, Active‐Comparator Trial" (98) and "Current and Developing Methods of Patient-Controlled Analgesia" (95).

Most cited papers
#PaperReleasedCitations
1 Research design considerations for chronic pain prevention clinical trials Jennifer S. Gewandter et al. · Pain Open access 16 Apr 2015 145
2 Sufentanil Sublingual Tablet System vs. Intravenous Patient‐Controlled Analgesia with Morphine for Postoperative Pain Control: A Randomized, Active‐Comparator Trial Timothy I. Melson, David L. Boyer, Harold S. Minkowitz et al. · Pain Practice Open access 25 Aug 2014 98
3 Current and Developing Methods of Patient-Controlled Analgesia Pamela Pierce Palmer, Ronald D. Miller · Anesthesiology Clinics 12 Nov 2010 95
4 Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations Sandra D. Comer et al. · Pain Open access 19 Sep 2012 74
5 Sufentanil Sublingual Tablet System for the Management of Postoperative Pain Following Open Abdominal Surgery Forrest G. Ringold, Harold S. Minkowitz, Tong Joo Gan et al. · Regional Anesthesia & Pain Medicine Open access 15 Oct 2014 56
All 44 most cited papers, with filters and sorting

Which keywords describe research at AcelRx Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Pain Management, Postoperative Pain, Chronic Pain, Pain Assessment Tools, Elderly Patients, Analgesia, Regional Anesthesia and Surgical Outcome.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Pain Management10▲ 177×4 topics
  2. Postoperative Pain8▲ 333×3 topics
  3. Chronic Pain7▲ 118×4 topics
  4. Pain Assessment Tools6▲ 446×2 topics
  5. Elderly Patients4▲ 140×2 topics
  6. Analgesia4▲ 236×2 topics
  7. Regional Anesthesia4▲ 296×1 topic
  8. Surgical Outcome4▲ 296×1 topic
  9. Cancer Pain4▲ 598×1 topic
  10. Opioid Analgesics4▲ 598×1 topic
  11. Pharmacokinetics3▲ 42×4 topics
  12. Sedation3▲ 128×2 topics
  13. Inflammation2▲ 4.2×7 topics
  14. Anesthesia2▲ 77×2 topics
  15. Bispectral Index Monitoring2▲ 193×1 topic
  16. Dexmedetomidine2▲ 193×1 topic
  17. Pain Measurement2▲ 294×1 topic
  18. Pediatric Pain2▲ 294×1 topic
  19. Cancer1▲ 3.6×4 topics
  20. Chronic Pain Management1▲ 197×1 topic
  21. Opioid Prescribing1▲ 197×1 topic

Which research topics does AcelRx Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Diet and metabolism studies, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Cancer, Hypoxia, and Metabolism and Neonatal Health and Biochemistry.

Diet and metabolism stud…0Diet and metabolism studies: 0 fractional worksHyperglycemia and glycem…0Hyperglycemia and glycemic control in critically ill and hospitalized patients: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksNeonatal Health and Biochemistry: 0 fractional worksBlood groups and transfusion: 0 fractional worksHemoglobinopathies and R…0Hemoglobinopathies and Related Disorders: 0 fractional works
PhysiologyEndocrinology, Diabetes and MetabolismCancer ResearchPediatrics, Perinatology and Child Health2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diet and metabolism studies Physiology 0 works
  2. 2 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  4. 4 Neonatal Health and Biochemistry Pediatrics, Perinatology and Child Health 0 works
  5. 5 Blood groups and transfusion Hematology 0 works
  6. 6 Hemoglobinopathies and Related Disorders Genetics 0 works
  7. 7 Acute Kidney Injury Research Nephrology 0 works
  8. 8 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
  9. 9 Heparin-Induced Thrombocytopenia and Thrombosis Surgery 0 works
  10. 10 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.6%not open64.4%

World: 40% of research is openly available.

with international co-authors22.2%domestic only77.8%

World: 18% is written across borders.

How has AcelRx Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 64% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is AcelRx Pharmaceuticals (United States) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.00010%0.00020%0.00030%AcelRx Pharmaceuticals (United States)0.0000078% in 202520102020

Fractional works of AcelRx Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Redwood City

All research institutions in Redwood City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AcelRx Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.